Navigation Links
MiMedx Announces Its Support Of New CMS Packaging Payment Policy For Skin Substitutes
Date:11/29/2013

MARIETTA, Ga., Nov. 29, 2013 /PRNewswire/ -- MiMedx Group, Inc.  (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that the Company applauds the Centers for Medicare and Medicaid Services' (CMS) new methodology for the reimbursement of skin substitutes in the hospital outpatient setting, which was released on November 27, 2013.  Under the new Hospital Outpatient Prospective Payment System (OPPS) Final Rule, CMS will package the reimbursement for certain products used in advanced wound care with the related surgical procedure into a two-tier payment system. Additionally, the MiMedx allograft, EpiFix®, was extended pass-through status through 2014, which means it will retain the current payment methodology for one more year. CMS states that pass-through payments are intended to facilitate the adoption of certain new products for a period of at least two, but not more than three years.  EpiFix® will retain this status for 2014, which will be the third and final year. 

"We think that CMS has made very rational decisions that balance all the variables to protect their Medicare patients, manufacturers and our tax dollars. These changes were absolutely necessary to correct cost disparities and graft wastage in advanced wound care," said Parker H. Petit, Chairman and CEO."MiMedx has been an advocate of these changes and has lobbied Congress to support CMS in this initiative. We have spent considerable time with congressional members explaining to them the excessive wastage that has transpired in this area of healthcare.  We believe this new two-tier reimbursement policy will reduce excessive spending and broaden patient access to advanced wound care, which will benefit Medicare recipients. We applaud CMS for making this policy change." <
'/>"/>

SOURCE MiMedx Group, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. MiMedx To Present At Canaccord Genuity Medical Technology And Diagnostics Forum
2. MiMedx Announces Record Third Quarter Results
3. MiMedx Reports On Meeting With FDA
4. MiMedx Responds To Misleading And Inaccurate Media Reports
5. MiMedx Plantar Fasciitis Study Published In The Foot & Ankle International Journal
6. MiMedx To Present At 33rd Annual Canaccord Genuity Growth Conference
7. Mimedx Scientific Study Is Electronically Published in The International Wound Journal
8. MiMedx Announces Record Second Quarter Results
9. BioTech Companies in the News - Alliqua, Transition Therapeutics, Organovo, MiMedx Group, Keryx Biopharmaceuticals
10. MiMedx To Exceed High End Of Second Quarter Guidance
11. MiMedx to Ring NASDAQ Stock Market Opening Bell
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... 17, 2015 BellBrook Labs announced ... support for the powerful Orthogonal Pooled Screening (OPS) ... Center at the Lankenau Institute for Medical Research ... to measurably improve successful drug discovery outcomes using ... rare, drug-like libraries available nowhere else, coupled to ...
(Date:4/16/2015)... South San Francisco, CA (PRWEB) April 16, 2015 ... it is scheduled to report first quarter results on ... Following the announcement, Cytokinetics’ senior management will host a ... operational and financial results and the company’s outlook for ... webcast and can be accessed from the homepage and ...
(Date:4/16/2015)... Regis Technologies looks forward to being ... Research (AACR) annual meeting. Regis will exhibit at this ... April 18, in Philadelphia and running through April 22, ... the oldest and largest organization focused on cancer research. ... partners with survivors to promote awareness and research funding. ...
(Date:4/16/2015)... 2015  In recognition of World Hemophilia Day, Biogen ... to illuminate more than 15 prominent landmarks red throughout ... Zakim Bridge and Prudential Tower, Chicago,s ... Mercedes-Benz Superdome and Denver,s Coors ... April 17, and coincide with hemophilia community events in a ...
Breaking Biology Technology:BellBrook Labs and Lankenau Institute Partner to Accelerate Drug Discovery using Orthogonal Pooled Screening 2Cytokinetics to Announce First Quarter Results on April 30, 2015 2Cytokinetics to Announce First Quarter Results on April 30, 2015 3Regis Technologies Joins American Association for Cancer Research Annual Meeting 2Biogen Shines A Light On Hemophilia Community By Illuminating U.S. Landmarks Red On World Hemophlia Day 2Biogen Shines A Light On Hemophilia Community By Illuminating U.S. Landmarks Red On World Hemophlia Day 3Biogen Shines A Light On Hemophilia Community By Illuminating U.S. Landmarks Red On World Hemophlia Day 4
... Sept. 15, 2011 Each year, thousands of Amgen ... to a variety of charitable organizations. To recognize these exceptional ... of the 2011 Amgen Excellence in Volunteering Awards. ... States (U.S.) and Puerto Rico who are making a ...
... SEATTLE, Sept. 15, 2011 The Allen Institute for Brain ... cells in the spinal cord that act like neural stem ... to treat spinal cord injury and disease. The published collaborative ... the Allen Institute for Brain Science and The Montreal Neurological ...
... Sept. 15, 2011 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: ... a leading China-based pharmaceutical and biotechnology research and ... Ltd. ("Hengrui"), a leading Chinese pharmaceutical company, today ... subsidiary of ShangPharma, and Hengrui have entered into ...
Cached Biology Technology:Amgen Staff Volunteer Efforts Result in $5,000 For Each of Their Favorite Nonprofits 2Amgen Staff Volunteer Efforts Result in $5,000 For Each of Their Favorite Nonprofits 3New Class of Stem Cell-Like Cells Discovered in Spinal Cord Offers Possibilities for Spinal Cord Repair 2New Class of Stem Cell-Like Cells Discovered in Spinal Cord Offers Possibilities for Spinal Cord Repair 3ShangPharma Subsidiary and Jiangsu Hengrui Medicine Partner in Therapeutic Antibody Research and Development 2ShangPharma Subsidiary and Jiangsu Hengrui Medicine Partner in Therapeutic Antibody Research and Development 3
(Date:3/31/2015)... , March 31, 2015   Guidepoint , ... launch of the Post-Surgical Pain Management TRACKER, part of ... tracking usage trends in the medical device and therapeutics ... to data including treatment volumes, market share, and adoption ... pain associated with joint surgery. The Post-Surgical ...
(Date:3/24/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/hdgz7h/global_iris ) has ... Market 2015-2019" report to their offering. ... grow at a CAGR of 23.5 percent over the ... scenario and the growth prospects of the Global Iris ... market size, the report considers the revenue generated from ...
(Date:3/24/2015)... PALM BEACH GARDENS, Fla. , March 24, ... of biometric identity management solutions, today announced that ... enabling premium clothing accessory retailer Goorin Bros ... login. The Crossmatch biometrics-based solution secures access to ... customers from the increased risk of data breaches. ...
Breaking Biology News(10 mins):Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2
... continue to develop as two of the most exciting ... the public is almost completely unaware of the science ... adults conducted by Peter D. Hart Research Associates and ... percent of Americans think the public should be better ...
... Sept. 29From scopes that help premature babies breathe to techniques ... the latest optical and laser technology being deployed in medicine ... Society,s (OSA) Annual Meeting, Frontiers in Optics (FiO), which takes ... the Sainte Claire Hotel in San Jose, Calif. Information ...
... (GSA) Past President Judith Totman Parrish recently named Judge ... GSA,s prestigious President,s Medal. Parrish will present the award ... Ceremony on Saturday, 17 October, 7𔃇 p.m., at the ... fitting that Judge Jones receive this medal in 2009, ...
Cached Biology News:Nanotechnology and synthetic biology: What does the American public think? 2Bio-optics breakthroughs: Highlights of medical and bioscience research at Frontiers in Optics 2009 2Bio-optics breakthroughs: Highlights of medical and bioscience research at Frontiers in Optics 2009 3Bio-optics breakthroughs: Highlights of medical and bioscience research at Frontiers in Optics 2009 4Bio-optics breakthroughs: Highlights of medical and bioscience research at Frontiers in Optics 2009 5Bio-optics breakthroughs: Highlights of medical and bioscience research at Frontiers in Optics 2009 6Bio-optics breakthroughs: Highlights of medical and bioscience research at Frontiers in Optics 2009 7Geological Society of America honors Judge Jones for upholding science in the classroom 2Geological Society of America honors Judge Jones for upholding science in the classroom 3
The Sony UPD895 printer is used to print data captured with the Gel Doc XR and ChemiDoc XRS gel documentation systems as well as the VersaDoc imaging systems....
... from plants in 96 well plates. Plant materials are ... using large zirconia beads optimized for even tough plant ... through Mo Bio). Cells are lysed and DNA is ... DNA is washed and then released into 10 mM ...
... known as ChemiArrayTM Mouse Cytokine Antibody ... current methodologies. Besides the ability to ... a more accurate reflection of active ... secreted cytokines, and no amplification step ...
Request Info...
Biology Products: